Back to Agenda
Session 8: Senior Leaders Town Hall Session
Session Chair(s)
Mat Soukup, PHD
Deputy Director, Division of Biometrics VII, OB, OTS CDER, FDA, United States
Karen Lynn Price, PHD
Senior Research Fellow, Statistical Innovation Center/Design Hub, Eli Lilly and Company, United States
If hindsight is 20/20, the year 2020 seems an opportune time to reflect on the past decades of clinical research to gain a clearer understanding of where we’ve been, key lessons we have learned, and apply learnings from the past to tackle tomorrow’s challenges. In this session, senior leaders from the biostatistics community will share examples and provide insights from their own personal experiences on topics from the past that were innovative historically but are commonplace today. These leaders will reflect on the lessons learned and keys to the successful adoption of more innovative approaches to address challenges. Alternatively, innovative ideas that failed to progress may be discussed in an effort to learn for the future.
Learning Objective :
At the conclusion of this session, participants should be able to:
- Identify opportunities for statistical engagement
- Apply lessons learned from experienced professionals
- Recognize the importance of statistical thinking in clinical research
Speaker(s)
Sylva Heghinian Collins, PHD
Director, Office of Biostatistics, FDA, CDER, FDA, United States
Speaker
John Scott, PHD, MA
Division Director, Office of Biostatistics, CBER, FDA, United States
Speaker
Ram Tiwari, PHD, MS
Head of Statistical Methodology, Bristol Myres Squibb , United States
Speaker
Pandurang M Kulkarni, PHD
Chief Analytics Officer-R&D / Vice President of Statistics, Data & Analytics, Eli Lilly and Company, United States
Speaker
Lisa Lupinacci, PHD, MS
Senior Vice President, Biostatistics and Research Decision Sciences, Merck and Co., Inc., United States
Speaker
Amy Xia, PHD
Vice President, Center for Design and Analysis, Amgen Inc., United States
Speaker
Have an account?